'Fingerprint database' could help pinpoint environmental cancer causes
Until now, scientists have had only a limited number of tools for working out the cause of an individual’s tumour.
18th April 2019
-
Where now for pharma?
Steve How and Paul Midgley, of Wilmington Healthcare, explore the diverse needs of local NHS health economies as they respond to the Long Term Plan’s demands for joined-up, holistic care
-
In sickness and in health
In its finest hours, the bond between patients and pharma can move mountains, defy disease and change the course of history
-
The human factor
Richard McAleavy considers what autonomous cars can teach digital healthcare about building engagement
News
View all
NICE final guidance published for Cimzia
For adults who have failed to respond to, or are unsuitable for, other systemic therapies.
18th April 2019
Public ‘unaware’ they have a choice of hospitals for NHS treatment
The legal right to choice has been in place for over a decade, but just 48% of the public are currently aware of it.
18th April 2019
PureTech Health, Boehringer Ingelheim enter $26M immuno-oncology deal
PureTech Health will receive up to $26 million under the transaction.
18th April 2019
Tickets available for the 20th International Clinical Researcher of the Year gala dinner & awards ceremony
Tickets are available for those wanting to be a part of one of the most important dates in the clinical research calendar – an evening of celebration and recognition for the very best clinical researchers from across the globe
17th April 2019
Top trending
-
EMA recommends temporarily restricting Lemtrada use in MS
-
BMS, Celgene shareholders back mega merger
-
‘Landmark’ day for Akcea as NICE recommends Tegsedi in rare inherited hATTR
-
Trial results show promise for chemo-free future treatment
-
Novartis’ wet AMD drug gets FDA filing
-
AI could identify existing drugs to help treat eye disease
Web Exclusives
View all
Nothing less than a bleed-free life
To mark World Haemophilia Day, Laurence Woollard talks to PharmaTimes about engaging today’s generation of young people living with the condition to advocate for nothing less than a bleed-free life
Lonely at the top?
Ex England cricketer Jeremy Snape says pharma leaders looking to inspire their teams during volatile times should see what lessons they can learn from other industries faced with similar challenges
The search for a cure for Alzheimer’s is far from over
Patent-mapping research suggests that innovation-led newcomers may already be on to something new
AI and pharma sales
Alex Dale looks at where we are with AI and how it might help pharma sales
Magazine
View more from the latest edition
Where now for pharma?
Steve How and Paul Midgley, of Wilmington Healthcare, explore the diverse needs of local NHS health economies as they respond to the Long Term Plan’s demands for joined-up, holistic care
In sickness and in health
In its finest hours, the bond between patients and pharma can move mountains, defy disease and change the course of history
A state of confusion
The prospect of Brexit-related drugs shortages is looming, although a snarl-up may yet be avoided
The human factor
Richard McAleavy considers what autonomous cars can teach digital healthcare about building engagement
SmartPeople: Eric Hughes
We talk to Eric Hughes about his role as Novartis’ global development unit head of Immunology, Hepatology and Dermatology
Change mindset, change the future
How to orchestrate true value from customer engagement and achieve brand launch success
The long arm of the law
Sheena Linehan takes a look at the recent legal cases impacting the life sciences landscape
The pricing conundrum
Margaret Kyle takes a look at excessive pricing in the pharma industry
Thought Leadership
View all
Hidden gems
How can big pharma and SME pharma work to mutual advantage and help patients with unmet medical need?
The shortcut to a better patient experience
Richard Billington, chief technology officer of MatsSoft, explains how IT leaders can adapt to a patient-centric world
Clinical systems intelligence: raising the bar
Sam Grove, commercial director at Oberoi Consulting, explains how pharma companies can better achieve their brand objectives with training on clinical systems intelligence.
Search for the right patient - the personal label
Label – and label extension – strategy is starting to shift from a broader and broader focus to a very specific one
Webinars
View allDesigning Pharma organisations for success
Across all industries, people are changing the ways they engage with products, services, and brands. View more...
Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW
